CBP and ICE Chiefs Faced Off Against Unhinged Dems...and One Said the Quiet...
Democrat Presidential Hopeful Has Been Telling Some Weird Lies About His Ancestor and...
DOJ Charges Two Men in $120 Million Adult Day Care Fraud Scheme
This GOP Governor Just Shot Down a Bill That Would Have Banned Biological...
Chewing the Fat on the Left's 'Body Positivity' Flip Flop
National Nurses Union Calls for the Abolition of ICE
While Her Senate Rivals Campaign Statewide, Haley Stevens Hides From Voters
Delaware Smacked Down for Trying to Enforce Law, Ignoring Injunction
Dow 50,000: A Supply-Side Miracle
Tensions Rise At the White House's New Religious Liberty Commission as One Member...
Mike Johnson Blasts Mamdani's DOH for Creating a ‘Global Oppression’ Group Focused on...
Kentucky Senate Candidate Andy Barr Endorses Pro-Amnesty Book Despite Pledging to Be ‘Amer...
Even CNN Knows That Democrats Are on the Wrong Side of the Voter...
Ken Paxton Notches Immigration Win As Premier Community for Illegals Pays Out $68...
This Congressman's Inquiry Into Bad Bunny's Explicit Performance Has the Libs Screaming
Tipsheet

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine

AP Photo/Rogelio D. Solis

Moderna announced on Thursday it had begun development for a potential single-dose vaccine that is a combination of a Wuhan coronavirus vaccine booster shot and seasonal flu shot. 

Advertisement

In a press release published Thursday, Moderna CEO Stephane Bancel announced the new development and shared the progress of other programs the company is working on, such as their “cancer vaccine.” 

“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”

As we previously reported, Moderna informed investors and analysts last month that the company was planning for a booster COVID-19 shot in addition to its already-existing two-dose mRNA vaccine shot. As of right now, the Moderna COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be administered to prevent the spread of COVID-19. However, the vaccine has not been fully approved by the FDA.

Advertisement

Related:

COVID-19 VACCINE

“We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Bancel said in a statement last month announcing plans for a potential booster shot. In the statement, Bancel also said Moderna is “looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and RSV for adults.”

Perhaps that vision could be on the horizon with this hybrid coronavirus/flu vaccine in the works. This week, however, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus reiterated his call for a halt on COVID-19 booster shots through the end of the year. Moderna has not revealed when it plans to have the booster shot completed.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos